| 4E20: reference: Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor., Argiriadi MA, Goedken ER, Banach D, Borhani DW, Burchat A, Dixon RW, Marcotte D, Overmeyer G, Pivorunas V, Sadhukhan R, Sousa S, Moore NS, Tomlinson M, Voss J, Wang L, Wishart N, Woller K, Talanian RV, BMC Struct Biol. 2012 Sep 20;12(1):22. PMID: 22995073 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).